Akebia Therapeutics, Inc. (AKBA): Price and Financial Metrics
AKBA Price/Volume Stats
| Current price | $3.97 | 52-week high | $4.00 |
| Prev. close | $3.69 | 52-week low | $0.80 |
| Day low | $3.66 | Volume | 8,184,500 |
| Day high | $4.00 | Avg. volume | 4,098,947 |
| 50-day MA | $2.42 | Dividend yield | N/A |
| 200-day MA | $1.95 | Market Cap | 1.04B |
AKBA Stock Price Chart Interactive Chart >
Akebia Therapeutics, Inc. (AKBA) Company Bio
Akebia Therapeutics focuses on the development and commercialization of proprietary therapeutics based on hypoxia inducible factor (HIF) biology for patients with kidney disease. The company was founded in 2007 and is based in Cambridge, Massachusetts.
AKBA Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
AKBA Price Returns
| 1-mo | 51.53% |
| 3-mo | 108.95% |
| 6-mo | 94.61% |
| 1-year | 274.53% |
| 3-year | 791.93% |
| 5-year | -66.41% |
| YTD | 108.95% |
| 2024 | 53.23% |
| 2023 | 114.90% |
| 2022 | -74.47% |
| 2021 | -19.29% |
| 2020 | -55.70% |